Related Experiment Video
Updated: Mar 25, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections
Cristina Cigana1, Nicola Ivan Lorè1, Camilla Riva1
1Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milano, Italy.
Abstract:
Repeated cycles of infections, caused mainly by Pseudomonas aeruginosa, combined with a robust host immune response and tissue injury, determine the course and outcome of cystic fibrosis (CF) lung disease. As the disease progresses, P. aeruginosa adapts to the host modifying dramatically its phenotype; however, it remains unclear whether and how bacterial adaptive variants and their persistence influence the pathogenesis and disease development. Using in vitro and murine models of infection, we showed that P. aeruginosa CF-adaptive variants shaped the innate immune response favoring their persistence. Next, we refined a murine model of chronic pneumonia extending P. aeruginosa infection up to three months. In this model, including CFTR-deficient mice, we unveil that the P. aeruginosa persistence lead to CF hallmarks of airway remodelling and fibrosis, including epithelial hyperplasia and structure degeneration, goblet cell metaplasia, collagen deposition, elastin degradation and several additional markers of tissue damage. This murine model of P. aeruginosa chronic infection, reproducing CF lung pathology, will be instrumental to identify novel molecular targets and test newly tailored molecules inhibiting chronic inflammation and tissue damage processes in pre-clinical studies.
Insights
Pseudomonas aeruginosa adaptive variants in cystic fibrosis (CF) lung disease promote bacterial persistence by influencing the immune response. A new chronic infection mouse model reveals how bacterial persistence drives CF lung pathology and fibrosis.
Area of Science:
- Microbiology
- Immunology
- Pathology
Background:
- Cystic fibrosis (CF) lung disease is characterized by recurrent Pseudomonas aeruginosa infections, host immune responses, and tissue injury.
- P. aeruginosa adapts to the CF lung environment, but the role of bacterial adaptive variants in disease progression remains unclear.
Purpose of the Study:
- To investigate the influence of P. aeruginosa adaptive variants on the host immune response and bacterial persistence.
- To develop and utilize a refined murine model of chronic P. aeruginosa infection to study CF lung disease pathogenesis.
Main Methods:
- In vitro and murine infection models were used to assess P. aeruginosa adaptive variants' impact on the innate immune response.
- A chronic pneumonia murine model, including CFTR-deficient mice, was established to mimic P. aeruginosa chronic infection for up to three months.
Main Results:
- P. aeruginosa CF-adaptive variants were shown to modulate the innate immune response, promoting their own persistence.
- The refined murine model demonstrated that P. aeruginosa persistence leads to CF hallmarks such as airway remodeling, fibrosis, epithelial hyperplasia, and tissue damage.
Conclusions:
- P. aeruginosa persistence, driven by adaptive variants, significantly contributes to CF lung pathology, including airway remodeling and fibrosis.
- The developed chronic infection mouse model accurately reproduces key aspects of CF lung disease and serves as a valuable tool for pre-clinical studies targeting inflammation and tissue damage.
Related Concept Videos
Atypical Pneumonia
Pneumonia II: Pathophysiology
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Microbiota of the Respiratory Tract
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

